GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AVEO Pharmaceuticals Inc (STU:VPA1) » Definitions » E10

AVEO Pharmaceuticals (STU:VPA1) E10 : €-7.21 (As of Sep. 2022)


View and export this data going back to 2013. Start your Free Trial

What is AVEO Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AVEO Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2022 was €-0.091. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-7.21 for the trailing ten years ended in Sep. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-07), AVEO Pharmaceuticals's current stock price is €13.795. AVEO Pharmaceuticals's E10 for the quarter that ended in Sep. 2022 was €-7.21. AVEO Pharmaceuticals's Shiller PE Ratio of today is .


AVEO Pharmaceuticals E10 Historical Data

The historical data trend for AVEO Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVEO Pharmaceuticals E10 Chart

AVEO Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -37.47 -10.41 -5.70 -8.37

AVEO Pharmaceuticals Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.67 -8.37 -8.04 -7.25 -7.21

Competitive Comparison of AVEO Pharmaceuticals's E10

For the Biotechnology subindustry, AVEO Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVEO Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AVEO Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AVEO Pharmaceuticals's Shiller PE Ratio falls into.



AVEO Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AVEO Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2022 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=-0.091/125.2265*125.2265
=-0.091

Current CPI (Sep. 2022) = 125.2265.

AVEO Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201212 -3.734 96.871 -4.827
201303 -5.327 98.209 -6.792
201306 -4.700 98.518 -5.974
201309 -3.516 98.790 -4.457
201312 -2.336 98.326 -2.975
201403 -0.868 99.695 -1.090
201406 -2.576 100.560 -3.208
201409 -2.173 100.428 -2.710
201412 -2.190 99.070 -2.768
201503 -1.940 99.621 -2.439
201506 -0.891 100.684 -1.108
201509 1.247 100.392 1.555
201512 -1.102 99.792 -1.383
201603 -1.167 100.470 -1.455
201606 -1.157 101.688 -1.425
201609 -0.624 101.861 -0.767
201612 -0.664 101.863 -0.816
201703 -1.122 102.862 -1.366
201706 -2.670 103.349 -3.235
201709 -1.846 104.136 -2.220
201712 -0.676 104.011 -0.814
201803 -0.649 105.290 -0.772
201806 -0.514 106.317 -0.605
201809 -1.543 106.507 -1.814
201812 -0.264 105.998 -0.312
201903 -0.549 107.251 -0.641
201906 -0.177 108.070 -0.205
201909 0.926 108.329 1.070
201912 -0.252 108.420 -0.291
202003 -0.471 108.902 -0.542
202006 -0.373 108.767 -0.429
202009 -0.280 109.815 -0.319
202012 -0.362 109.897 -0.412
202103 -0.680 111.754 -0.762
202106 -0.332 114.631 -0.363
202109 -0.255 115.734 -0.276
202112 -0.186 117.630 -0.198
202203 -0.272 121.301 -0.281
202206 -0.227 125.017 -0.227
202209 -0.091 125.227 -0.091

Add all the adjusted EPS together and divide 10 will get our e10.


AVEO Pharmaceuticals  (STU:VPA1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


AVEO Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of AVEO Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


AVEO Pharmaceuticals (STU:VPA1) Business Description

Traded in Other Exchanges
N/A
Address
30 Winter Street, Boston, MA, USA, 02108
AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States. FOTIVDA is an oral, next-generation vascular endothelial growth factor receptor, or VEGFR, tyrosine kinase inhibitor, or TKI. The group primarily operates in the U.S.

AVEO Pharmaceuticals (STU:VPA1) Headlines

No Headlines